{"id":348633,"date":"2026-11-16T14:20:38","date_gmt":"2026-11-16T08:50:38","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=348633"},"modified":"2026-11-16T14:20:38","modified_gmt":"2026-11-16T08:50:38","slug":"pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/","title":{"rendered":"3 Pharmaceuticals Company, Crop Protection Company and Cement Maker Stocks With a Strong Future Roadmap: Ajanta Pharma, Insecticides India and Star Cement"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Ajanta Pharma, Insecticides India and Star Cement: ROE of 11.4% to 23.3% and FY22 to FY26 revenue CAGR of 9.3% to 13.9%. Prices as of 13 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three pharma, crop care and cement stocks to watch are Ajanta Pharma, Insecticides India and Star Cement. Their return on equity ranges from 11.4% to 23.3%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.3% to 13.9%. Ajanta Pharma has the highest return on equity at 23.3%, while Star Cement has the fastest revenue growth at 13.9% a year. Prices are based on the 13 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Pharma, crop care and cement stocks bring together companies with a visible plan for the years ahead. Ajanta Pharma, Insecticides India and Star Cement cover a pharmaceuticals company, a crop protection company and a cement maker.<\/p>\n<p>This list covers three pharma, crop care and cement stocks with complete current figures: Ajanta Pharma, Insecticides India and Star Cement. Every figure comes from the latest reported financials and the 13 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#What_Are_Pharma_Crop_Care_and_Cement_Stocks\" title=\"What Are Pharma, Crop Care and Cement Stocks?\">What Are Pharma, Crop Care and Cement Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#Pharma_Crop_Care_and_Cement_Stocks_at_a_Glance\" title=\"Pharma, Crop Care and Cement Stocks at a Glance\">Pharma, Crop Care and Cement Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#Why_Do_Pharma_Crop_Care_and_Cement_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Pharma, Crop Care and Cement Stocks Have a Strong Roadmap in India?\">Why Do Pharma, Crop Care and Cement Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#Why_Ajanta_Pharma_Features_Among_These_Pharma_Crop_Care_and_Cement_Stocks\" title=\"Why Ajanta Pharma Features Among These Pharma, Crop Care and Cement Stocks\">Why Ajanta Pharma Features Among These Pharma, Crop Care and Cement Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#Why_Insecticides_India_Features_Among_These_Pharma_Crop_Care_and_Cement_Stocks\" title=\"Why Insecticides India Features Among These Pharma, Crop Care and Cement Stocks\">Why Insecticides India Features Among These Pharma, Crop Care and Cement Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#Why_Star_Cement_Features_Among_These_Pharma_Crop_Care_and_Cement_Stocks\" title=\"Why Star Cement Features Among These Pharma, Crop Care and Cement Stocks\">Why Star Cement Features Among These Pharma, Crop Care and Cement Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#Ajanta_Pharma_vs_Insecticides_India_vs_Star_Cement_on_Key_Financials\" title=\"Ajanta Pharma vs Insecticides India vs Star Cement on Key Financials\">Ajanta Pharma vs Insecticides India vs Star Cement on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#Key_Risks_to_Check_Before_Investing_in_Pharma_Crop_Care_and_Cement_Stocks\" title=\"Key Risks to Check Before Investing in Pharma, Crop Care and Cement Stocks\">Key Risks to Check Before Investing in Pharma, Crop Care and Cement Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#Final_Thoughts_on_Pharma_Crop_Care_and_Cement_Stocks\" title=\"Final Thoughts on Pharma, Crop Care and Cement Stocks\">Final Thoughts on Pharma, Crop Care and Cement Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#What_are_pharma_crop_care_and_cement_stocks\" title=\"What are pharma, crop care and cement stocks?\">What are pharma, crop care and cement stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#Which_pharma_crop_care_and_cement_stocks_are_covered_in_this_list\" title=\"Which pharma, crop care and cement stocks are covered in this list?\">Which pharma, crop care and cement stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#Why_do_pharma_crop_care_and_cement_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do pharma, crop care and cement stocks have a strong future roadmap in India?\">Why do pharma, crop care and cement stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#How_has_Ajanta_Pharma_performed_financially\" title=\"How has Ajanta Pharma performed financially?\">How has Ajanta Pharma performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#How_has_Insecticides_India_performed_financially\" title=\"How has Insecticides India performed financially?\">How has Insecticides India performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#How_has_Star_Cement_performed_financially\" title=\"How has Star Cement performed financially?\">How has Star Cement performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#What_risks_should_investors_check_before_buying_pharma_crop_care_and_cement_stocks\" title=\"What risks should investors check before buying pharma, crop care and cement stocks?\">What risks should investors check before buying pharma, crop care and cement stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-roadmap-moorland-list\/#Is_this_list_of_pharma_crop_care_and_cement_stocks_investment_advice\" title=\"Is this list of pharma, crop care and cement stocks investment advice?\">Is this list of pharma, crop care and cement stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Pharma_Crop_Care_and_Cement_Stocks\"><\/span><strong>What Are Pharma, Crop Care and Cement Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pharma, crop care and cement stocks are listed companies that make and sell branded medicines in India and abroad, make and sell crop protection products to farmers, and make cement for homes, roads and infrastructure. Their earnings depend on medicine demand, farm activity and construction activity.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Pharma_Crop_Care_and_Cement_Stocks_at_a_Glance\"><\/span><strong>Pharma, Crop Care and Cement Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/ajantpharm\/ajanta-pharma-ltd-share-price-today\">Ajanta Pharma<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,284<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">41,241<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.06<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/insecticid\/insecticides-(india)-ltd-share-price-today\">Insecticides India<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">539.95<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,507<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.13<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/starcement\/star-cement-ltd-share-price-today\">Star Cement<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">176.06<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6,481<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">29.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.19<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Insecticides India and Star Cement trade at a P\/E below the industry P\/E, while Ajanta Pharma trades above it, which reflects the growth the market already expects. Readers comparing pharma, crop care and cement stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Pharma_Crop_Care_and_Cement_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Pharma, Crop Care and Cement Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pharma, crop care and cement stocks have a strong roadmap in India because growing demand for quality medicines, wider use of crop care inputs and heavy spending on housing and roads keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Pharmaceuticals.<\/strong> Patients need quality medicines.<\/li>\n<li><strong>Crop protection.<\/strong> Farmers protect their crops.<\/li>\n<li><strong>Cement.<\/strong> Roads and homes need cement.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Ajanta_Pharma_Features_Among_These_Pharma_Crop_Care_and_Cement_Stocks\"><\/span><strong>Why Ajanta Pharma Features Among These Pharma, Crop Care and Cement Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the pharma, crop care and cement stocks on this list, Ajanta Pharma is a specialty pharmaceutical company that sells branded generics in India and in emerging markets across Asia and Africa, with a focus on ophthalmology, dermatology, cardiology and pain management, and also sells generics in the United States.<\/p>\n<p>Revenue rose from Rs 3,457 crore in FY22 to Rs 5,625 crore in FY26, a compound annual growth rate of 12.9%. Net profit grew from Rs 713 crore in FY22 to Rs 1,056 crore in FY26, which works out to a compound annual growth rate of 10.3%.<\/p>\n<p>In the June 2026 quarter, revenue grew 27.7% year on year to Rs 1,697 crore, while net profit rose 30.9% to Rs 334 crore. The company has a return on equity of 23.3%, a debt to equity ratio of 0.06 and a market capitalisation of Rs 41,241 crore. The stock trades at a P\/E of 36.3, above the industry P\/E of 36.0.<\/p>\n<p><strong>Roadmap:<\/strong> The company concentrates on niche therapies where it holds leading positions and has a wide field force in India and Africa. A steady flow of new launches and a debt-free balance sheet support expansion in branded markets.<\/p>\n<p><strong>What to watch:<\/strong> Monitor the pace of new launches in branded markets and the momentum in the United States generics business.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Insecticides_India_Features_Among_These_Pharma_Crop_Care_and_Cement_Stocks\"><\/span><strong>Why Insecticides India Features Among These Pharma, Crop Care and Cement Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the branded medicine, pesticide maker and building material shares on this list, Insecticides India is a Delhi-based crop protection company that makes and sells insecticides, herbicides and fungicides to farmers through a wide network of dealers and distributors.<\/p>\n<p>Revenue rose from Rs 1,508 crore in FY22 to Rs 2,152 crore in FY26, a compound annual growth rate of 9.3%. Net profit grew from Rs 107 crore in FY22 to Rs 139 crore in FY26, which works out to a compound annual growth rate of 6.7%.<\/p>\n<p>The company has a return on equity of 11.4%, a debt to equity ratio of 0.13 and a market capitalisation of Rs 1,507 crore. The stock trades at a P\/E of 12.0, below the industry P\/E of 21.9.<\/p>\n<p><strong>Roadmap:<\/strong> The company is launching new formulations and growing its own brands, which supports better margins. Rising demand for crop protection from Indian farmers supports steady volumes.<\/p>\n<p><strong>What to watch:<\/strong> Follow monsoon trends, new product launches and technical raw material costs.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Star_Cement_Features_Among_These_Pharma_Crop_Care_and_Cement_Stocks\"><\/span><strong>Why Star Cement Features Among These Pharma, Crop Care and Cement Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Star Cement is a leading cement maker in India&#8217;s North East, producing cement at plants in Meghalaya and Assam and selling across the region and in eastern India.<\/p>\n<p>The company has a return on equity of 12.3%, a debt to equity ratio of 0.19 and a market capitalisation of Rs 6,481 crore. The stock trades at a P\/E of 17.7, below the industry P\/E of 29.6.<\/p>\n<p>Revenue rose from Rs 2,255 crore in FY22 to Rs 3,796 crore in FY26, a compound annual growth rate of 13.9%. Net profit grew from Rs 247 crore in FY22 to Rs 390 crore in FY26, which works out to a compound annual growth rate of 12.2%. In the June 2026 quarter, revenue grew 4.1% year on year to Rs 951 crore.<\/p>\n<p><strong>Roadmap:<\/strong> The company is expanding capacity and widening its reach in eastern India, while infrastructure and housing spending in the North East supports demand. Its strong regional position helps pricing.<\/p>\n<p><strong>What to watch:<\/strong> Follow regional cement prices, capacity expansion and fuel and freight costs.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Ajanta_Pharma_vs_Insecticides_India_vs_Star_Cement_on_Key_Financials\"><\/span><strong>Ajanta Pharma vs Insecticides India vs Star Cement on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three pharma, crop care and cement stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Ajanta Pharma<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,457<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,625<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.9%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,056<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Insecticides India<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,508<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,152<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.3%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">139<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Star Cement<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,255<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,796<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.9%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">390<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.3%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Ajanta Pharma posts the highest return on equity in this group at 23.3%. Ajanta Pharma has the largest FY26 revenue at Rs 5,625 crore, and Star Cement shows the fastest revenue growth with a 13.9% compound annual rate. A useful habit with pharma, crop care and cement stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Pharma_Crop_Care_and_Cement_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Pharma, Crop Care and Cement Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these pharma, crop care and cement stocks, the main points are: Long-term branded medicine, pesticide maker and building material shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Regulatory approvals.<\/strong> Plant inspections and approvals can affect supplies.<\/li>\n<li><strong>Season and monsoon.<\/strong> Crop protection sales follow rain and pest cycles.<\/li>\n<li><strong>Raw material costs.<\/strong> Ingredient and packaging prices can move margins.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter pharma, crop care and cement stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Pharma_Crop_Care_and_Cement_Stocks\"><\/span><strong>Final Thoughts on Pharma, Crop Care and Cement Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pharma, crop care and cement stocks suit investors who prefer to study business strength before price moves. Ajanta Pharma, Insecticides India and Star Cement each have a clear plan to grow. Based on the 13 November 2026 close, Ajanta Pharma trades at Rs 3,284, Insecticides India at Rs 539.95 and Star Cement at Rs 176.06.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track pharma, crop care and cement stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_pharma_crop_care_and_cement_stocks\"><\/span><strong>What are pharma, crop care and cement stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pharma, crop care and cement stocks are listed companies that make and sell branded medicines in India and abroad, make and sell crop protection products to farmers, and make cement for homes, roads and infrastructure. Their earnings depend on medicine demand, farm activity and construction activity. This list looks at three of them, Ajanta Pharma, Insecticides India and Star Cement, using reported FY22 to FY26 financials and the 13 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_pharma_crop_care_and_cement_stocks_are_covered_in_this_list\"><\/span><strong>Which pharma, crop care and cement stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Ajanta Pharma, Insecticides India and Star Cement. Based on the 13 November 2026 close, Ajanta Pharma traded at Rs 3,284, Insecticides India at Rs 539.95 and Star Cement at Rs 176.06. Their return on equity ranges from 11.4% to 23.3%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.3% to 13.9%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_pharma_crop_care_and_cement_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do pharma, crop care and cement stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pharma, crop care and cement stocks have a strong roadmap in India because growing demand for quality medicines, wider use of crop care inputs and heavy spending on housing and roads keep widening the market for these companies. The main drivers are as follows. Pharmaceuticals. Patients need quality medicines. Crop protection. Farmers protect their crops. Cement. Roads and homes need cement. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Ajanta_Pharma_performed_financially\"><\/span><strong>How has Ajanta Pharma performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 3,457 crore in FY22 to Rs 5,625 crore in FY26, a compound annual growth rate of 12.9%. Net profit grew from Rs 713 crore in FY22 to Rs 1,056 crore in FY26, which works out to a compound annual growth rate of 10.3%. In the June 2026 quarter, revenue grew 27.7% year on year to Rs 1,697 crore, while net profit rose 30.9% to Rs 334 crore. The company has a return on equity of 23.3%, a debt to equity ratio of 0.06 and a market capitalisation of Rs 41,241 crore. The stock trades at a P\/E of 36.3, above the industry P\/E of 36.0. Looking ahead, the company concentrates on niche therapies where it holds leading positions and has a wide field force in India and Africa. A steady flow of new launches and a debt-free balance sheet support expansion in branded markets.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Insecticides_India_performed_financially\"><\/span><strong>How has Insecticides India performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 1,508 crore in FY22 to Rs 2,152 crore in FY26, a compound annual growth rate of 9.3%. Net profit grew from Rs 107 crore in FY22 to Rs 139 crore in FY26, which works out to a compound annual growth rate of 6.7%. The company has a return on equity of 11.4%, a debt to equity ratio of 0.13 and a market capitalisation of Rs 1,507 crore. The stock trades at a P\/E of 12.0, below the industry P\/E of 21.9. Looking ahead, the company is launching new formulations and growing its own brands, which supports better margins. Rising demand for crop protection from Indian farmers supports steady volumes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Star_Cement_performed_financially\"><\/span><strong>How has Star Cement performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 2,255 crore in FY22 to Rs 3,796 crore in FY26, a compound annual growth rate of 13.9%. Net profit grew from Rs 247 crore in FY22 to Rs 390 crore in FY26, which works out to a compound annual growth rate of 12.2%. In the June 2026 quarter, revenue grew 4.1% year on year to Rs 951 crore. The company has a return on equity of 12.3%, a debt to equity ratio of 0.19 and a market capitalisation of Rs 6,481 crore. The stock trades at a P\/E of 17.7, below the industry P\/E of 29.6. Looking ahead, the company is expanding capacity and widening its reach in eastern India, while infrastructure and housing spending in the North East supports demand. Its strong regional position helps pricing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_pharma_crop_care_and_cement_stocks\"><\/span><strong>What risks should investors check before buying pharma, crop care and cement stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying pharma, crop care and cement stocks. Regulatory approvals. Plant inspections and approvals can affect supplies. Season and monsoon. Crop protection sales follow rain and pest cycles. Raw material costs. Ingredient and packaging prices can move margins. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_pharma_crop_care_and_cement_stocks_investment_advice\"><\/span><strong>Is this list of pharma, crop care and cement stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 13 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are pharma, crop care and cement stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Pharma, crop care and cement stocks are listed companies that make and sell branded medicines in India and abroad, make and sell crop protection products to farmers, and make cement for homes, roads and infrastructure. Their earnings depend on medicine demand, farm activity and construction activity. This list looks at three of them, Ajanta Pharma, Insecticides India and Star Cement, using reported FY22 to FY26 financials and the 13 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which pharma, crop care and cement stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Ajanta Pharma, Insecticides India and Star Cement. Based on the 13 November 2026 close, Ajanta Pharma traded at Rs 3,284, Insecticides India at Rs 539.95 and Star Cement at Rs 176.06. Their return on equity ranges from 11.4% to 23.3%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.3% to 13.9%.\"}},{\"@type\":\"Question\",\"name\":\"Why do pharma, crop care and cement stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Pharma, crop care and cement stocks have a strong roadmap in India because growing demand for quality medicines, wider use of crop care inputs and heavy spending on housing and roads keep widening the market for these companies. The main drivers are as follows. Pharmaceuticals. Patients need quality medicines. Crop protection. Farmers protect their crops. Cement. Roads and homes need cement. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Ajanta Pharma performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 3,457 crore in FY22 to Rs 5,625 crore in FY26, a compound annual growth rate of 12.9%. Net profit grew from Rs 713 crore in FY22 to Rs 1,056 crore in FY26, which works out to a compound annual growth rate of 10.3%. In the June 2026 quarter, revenue grew 27.7% year on year to Rs 1,697 crore, while net profit rose 30.9% to Rs 334 crore. The company has a return on equity of 23.3%, a debt to equity ratio of 0.06 and a market capitalisation of Rs 41,241 crore. The stock trades at a P\/E of 36.3, above the industry P\/E of 36.0. Looking ahead, the company concentrates on niche therapies where it holds leading positions and has a wide field force in India and Africa. A steady flow of new launches and a debt-free balance sheet support expansion in branded markets.\"}},{\"@type\":\"Question\",\"name\":\"How has Insecticides India performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 1,508 crore in FY22 to Rs 2,152 crore in FY26, a compound annual growth rate of 9.3%. Net profit grew from Rs 107 crore in FY22 to Rs 139 crore in FY26, which works out to a compound annual growth rate of 6.7%. The company has a return on equity of 11.4%, a debt to equity ratio of 0.13 and a market capitalisation of Rs 1,507 crore. The stock trades at a P\/E of 12.0, below the industry P\/E of 21.9. Looking ahead, the company is launching new formulations and growing its own brands, which supports better margins. Rising demand for crop protection from Indian farmers supports steady volumes.\"}},{\"@type\":\"Question\",\"name\":\"How has Star Cement performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 2,255 crore in FY22 to Rs 3,796 crore in FY26, a compound annual growth rate of 13.9%. Net profit grew from Rs 247 crore in FY22 to Rs 390 crore in FY26, which works out to a compound annual growth rate of 12.2%. In the June 2026 quarter, revenue grew 4.1% year on year to Rs 951 crore. The company has a return on equity of 12.3%, a debt to equity ratio of 0.19 and a market capitalisation of Rs 6,481 crore. The stock trades at a P\/E of 17.7, below the industry P\/E of 29.6. Looking ahead, the company is expanding capacity and widening its reach in eastern India, while infrastructure and housing spending in the North East supports demand. Its strong regional position helps pricing.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying pharma, crop care and cement stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying pharma, crop care and cement stocks. Regulatory approvals. Plant inspections and approvals can affect supplies. Season and monsoon. Crop protection sales follow rain and pest cycles. Raw material costs. Ingredient and packaging prices can move margins. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of pharma, crop care and cement stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 13 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pharma, Crop Care and Cement Stocks with a strong future roadmap: Ajanta Pharma, Insecticides India and Star Cement. Compare price, valuation, return on equity and revenue growth as of 13 November 2026.<\/p>\n","protected":false},"author":29,"featured_media":348632,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[24249,13959,3803,12819,24247,22792,15765,24248,9963],"class_list":["post-348633","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-agrochemicals-and-northeast-cement-stocks","tag-ajanta-pharma","tag-best-stocks","tag-branded-medicine","tag-crop-care-and-cement-stocks","tag-formulations","tag-insecticides-india-2","tag-pesticide-maker-and-building-material-shares","tag-star-cement"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["348632"],"rank_math_title":["Pharma, Crop Care and Cement Stocks"],"rank_math_description":["Compare 3 pharma, crop care and cement stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 13 Nov 2026."],"rank_math_focus_keyword":["pharma, crop care and cement stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-pharmaceuticals-company-crop-protection-company-and-cement-maker-stocks-with-a.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/348633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=348633"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/348633\/revisions"}],"predecessor-version":[{"id":348634,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/348633\/revisions\/348634"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/348632"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=348633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=348633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=348633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}